RECRUITING

Primary Care Detection of Cognitive Impairment Leveraging Health & Consumer Technologies in Underserved Communities: The MyCog Trial

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Our study intends to offer 'real world' evidence of a viable, sustainable means to mobilize primary care via a comprehensive strategy for detecting cognitive impairment and dementias, advancing next steps for referral, and participating in the care planning and management of affected patients and caregivers. We will conduct a clinic-randomized, pragmatic trial testing the effectiveness and fidelity of our NIH Toolbox-derived paradigm to improve early detection and management of cognitive impairment/dementia in primary care settings serving health disparate patient populations.

Official Title

Primary Care Detection of Cognitive Impairment Leveraging Health & Consumer Technologies in Underserved Communities: The MyCog Trial

Quick Facts

Study Start:2024-01-30
Study Completion:2027-07-07
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05607732

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:45 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * been seen by an Oak Street healthcare provider affiliated with one of the 24 enrolled practices
  2. * had at least one clinic visit (routine or Annual Wellness Visit) during the 3-year study period
  3. * not been diagnosed previously with cognitive deficits, impairments or dementias.
  1. * Children, adolescence, and younger adults are excluded as cognitive impairment in these populations is often due to differences other than age-related changes.

Contacts and Locations

Study Contact

Michael S Wolf, PhD MPH
CONTACT
312-503-5592
mswolf@northwestern.edu
Morgan R Bonham, BS
CONTACT
312-503-1813
morgan.bonham@northwestern.edu

Study Locations (Sites)

Oak Street Health
Chicago, Illinois, 60617
United States

Collaborators and Investigators

Sponsor: Northwestern University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-01-30
Study Completion Date2027-07-07

Study Record Updates

Study Start Date2024-01-30
Study Completion Date2027-07-07

Terms related to this study

Keywords Provided by Researchers

  • Detect
  • Manage

Additional Relevant MeSH Terms

  • Dementia
  • Cognitive Impairment
  • Cognitive Decline
  • Alzheimer Disease